Sierra World Equity Review

Are Pfizer (PFE), Bristol-Myers Squibb (BMY) & Johnson & Johnson (JNJ) looking at Arena Pharmaceuticals (ARNA) as their next acquisition in the lucrative obesity drug market. Let the NEXT bidding war begin!

Sierra World Equity Review is the FIRST to forecast that the FDA will grant approval for Phase III trials to Oxigene, new drug ZYBRESTAT, a vascular disrupting agent program for neuroendocrine cancers, focused specifically on carcinoid syndrome.

Sierra World Equity Review predicts that All American Pet Company (AAPT) is about to become current on all it's necessary filings! While this has been expected and anticipated the reality of it is VERY significant!

Sierra World Equity Review is always on the cutting edge of the latest industry news. Arena Pharmaceuticals is about to have it's obesity weight loss drug Lorcaserin approved this week. Look for Pfizer to makes it move!

Sierra World Equity Review projects that the PPS of Highline Technical Innovation (HLNT) is about to undergo a correction.

Sierra World Equity review predicts that Lorcaserin, an obesity weight loss drug from Arena Pharmaceuticals will receive final approval this week.

You heard it here first! Sierra World Equity Review ventures that IC Places will be one of the smaller US companies tapping into the incredible opportunities open in China.

Sierra World Equity Review would not be surprised to see Tyco International (TYC) involved in a buyout of KMA Global Solutions. Sensormatic Retail Solutions is the global leader of Source Tagging and is part of the Tyco family of companies.

With Cannabis Science Inc. moving to expand internationally is an announcement of a joint venture with leading Cannabis Seed developer Dutch Passion of Amsterdam imminent.

What a way to end the week,how long will Sierra World Equity Review keep providing their amazing precise Winners and Losers stock picks for FREE! See how great they did again on Friday June 22nd 2012.